Matt, Abigail
Li, Yilin
Song, Andrew
Nix, Billy D.
Huang, Katherine
Jain, Umang
Ma, Changqing
Zhou, Chao
Deepak, Parakkal
Funding for this research was provided by:
National Science Foundation (GRFP)
National Institutes of Health (R21EB032684)
Litwin grant
Crohn’s and Colitis Foundation (IBD Plexus)
Helmsley Charitable trust
Leo & Carean Goss Crohn’s Disease Research Fund
Article History
Received: 19 November 2025
Accepted: 25 March 2026
First Online: 31 March 2026
Declarations
:
: P.D. has received research support under a sponsored research agreement unrelated to the data in the paper and/or consulting from AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Pfizer, Prometheus Biosciences, Takeda Pharmaceuticals, Roche Genentech, Scipher Medicine, Fresenius Kabi, Teva Pharmaceuticals, Landos Pharmaceuticals, Iterative scopes and CorEvitas, LLC. U.J. has received research support unrelated to this manuscript from Boehringer Ingelheim. The remaining authors declare no competing interests.